Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

New Breast Patient Navigator Certification Helps Clinical Coordinator Support Patients Along Their Breast Cancer Journey

PR Newswire December 3, 2014

Vaccinex to present its ActivMAb® Antibody Discovery Technology at the 2014 IBC Antibody Engineering & Therapeutics Conference

PR Newswire December 3, 2014

MY LIFE IS WORTH IT Calls for Balanced View of the Value of Advanced Therapeutics for Cancer Patients at Global Hematology Conference

Business Wire December 3, 2014

Enzo Biochem Schedules Teleconference to Discuss First Quarter Results Wednesday, December 10, 2014 at 8:30 AM E.T.

Business Wire December 3, 2014

CMC Biologics Announces Joseph Wypych, 20 Year Biopharmaceutical Executive, Joins as General Manager of Seattle Facility

PR Newswire December 3, 2014

THERAVECTYS Further Strengthens the Intellectual Property of Its Lentiviral Vector Technology

Business Wire December 3, 2014

Invitae Announces Reimbursement Coverage Decision by Blue Shield of California and Acceptance as a Medicare Provider

Business Wire December 3, 2014

Asthma and COPD Therapies Market Forecast 2014-2024

PR Newswire December 3, 2014

Shear genius: New ultrasound technology helps clinicians instantly assess body tissue that may be diseased

PR Newswire December 3, 2014

US Oncology Research Announces Schedule of Presentations at the 2014 American Society of Hematology Annual Meeting and Exposition

Business Wire December 3, 2014

Space Technology Unlocks Ancient Rituals

Canada NewsWire December 3, 2014

Joan Lunden to Keynote 32nd Annual Miami Breast Cancer Conference®

Business Wire December 3, 2014

Research and Markets: Spain Endoscopic Reprocessors Market Outlook to 2020: Key players covered include Olympus, Medivators, Steris, Getinge, Advanced Sterilization Products Services and Soluscope

Business Wire December 3, 2014

Research and Markets: BRIC Endoscopy Fluid Management Systems Market Outlook to 2020: Key players covered include Olympus, Stryker and KARL STORZ GmbH & Co

Business Wire December 3, 2014

UShareSoft Enables Cloud Providers and System Integrators to Scale Their Business with New Application Onboarding, Migration and Marketplace Services for Hybrid Environments

PR Newswire December 3, 2014

Epizyme to Webcast Company Presentation at American Society of Hematology (ASH) Annual Meeting on December 8, 2014

Business Wire December 3, 2014

AppDirect Adds Reseller Management Service to Its Platform, Solves Channel Pain Points in Selling Cloud Services

Business Wire December 3, 2014

Research and Markets: China General Surgery Outlook to 2020

Business Wire December 3, 2014

Milo Biotechnology Announces Patent Issuance

PR Newswire December 3, 2014

Organovo Collaborates with Yale team to develop 3-D Organ Tissues for Surgical Transplantation Research

PR Newswire December 3, 2014